We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Kinesio Taping and Inhibitory Treatment Techniques

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02859467
Recruitment Status : Unknown
Verified November 2020 by Adelaida María Castro-Sánchez, Universidad de Almeria.
Recruitment status was:  Active, not recruiting
First Posted : August 9, 2016
Last Update Posted : November 13, 2020
Sponsor:
Information provided by (Responsible Party):
Adelaida María Castro-Sánchez, Universidad de Almeria

Brief Summary:

Objective: Compare the benefits of Kinesio Taping and Inhibitory Treatment Techniques for Cervical, Thoracic and Lumbar Spine in Patients with Fibromyalgia Syndrome (FMS).

Study Design: A single-blind randomized controlled trial was conducted on patients with FMS.

Setting: Clinical setting. Methods: Sixty-four subjects with FMS were randomly assigned to an experimental group receiving kinesio taping and inhibitory treatment techniques, or to a control group for exercises and electrical stimulation therapy.


Condition or disease Intervention/treatment Phase
Fibromyalgia Other: Kinesio Taping and Inhibitory Treatment Techniques Other: Exercise and Electrical Stimulation Therapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 64 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Benefits of Kinesio Taping and Inhibitory Treatment Techniques in Patients With Fibromyalgia Syndrome
Actual Study Start Date : August 2016
Actual Primary Completion Date : November 2020
Estimated Study Completion Date : June 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fibromyalgia

Arm Intervention/treatment
Experimental: Kinesio Taping and Inhibitory Treatment Techniques

During each session participants will receive the application kinesio taping in trapezius, infraspinatus and paravertebral muscles.

Inhibitory Treatment Techniques:

  • Release Technique of the trapezius muscle.
  • Release Technique for scalene muscles.
  • Technique suboccipital inhibition.
  • Technique hands crossed for induction dorsal superficial fascia.
Other: Kinesio Taping and Inhibitory Treatment Techniques

Kinesio Taping on trapezius, infraspinatus, and paravertebral muscles

Inhibitory Treatment Techniques:

  • Release Technique of the trapezius muscle.
  • Release Technique for scalene muscles.
  • Technique suboccipital inhibition.
  • Technique hands crossed for induction dorsal superficial fascia.

Active Comparator: Exercise and Electrical Stimulation Therapy
Session for general physical activities (joint mobility, muscle strength and elasticity), and electrical stimulation therapy on para vertebral muscles.
Other: Exercise and Electrical Stimulation Therapy
Session for general physical activities (joint mobility, muscle strength and elasticity), and electrical stimulation therapy on para vertebral muscles.




Primary Outcome Measures :
  1. Pain Intensity [ Time Frame: Changes from Baseline, and 10 weeks ]
    A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain.


Secondary Outcome Measures :
  1. Quality of Life (SF-36) [ Time Frame: Changes from Baseline, and 10 weeks ]
  2. Pittsburgh Quality of Sleep Questionnaire [ Time Frame: Changes from Baseline, and 10 weeks ]
  3. Beck Inventory for Depression [ Time Frame: Changes from Baseline, and 10 weeks ]
  4. Fibromyalgia Impact Questionnaire (FIQ) [ Time Frame: Changes from Baseline, and 10 weeks ]
  5. Hospital Anxiety Depression Scale (HADS) [ Time Frame: Changes from Baseline, and 10 weeks ]
  6. State-Trait Anxiety Inventory (STAI) [ Time Frame: Changes from Baseline, and 10 weeks ]
  7. McGill Pain Questionnaire [ Time Frame: Changes from Baseline, and 10 weeks ]
  8. Fatigue Impact Scale [ Time Frame: Changes from Baseline, and 10 weeks ]
  9. Pain Pressure [ Time Frame: Changes from Baseline, and 10 weeks ]
  10. Schöber Test [ Time Frame: Changes from Baseline, and 10 weeks ]
  11. Widespread pain index [ Time Frame: Changes from Baseline, and 10 weeks ]
  12. Symptom severity score [ Time Frame: Changes from Baseline, and 10 weeks ]
  13. Measurement Finger-Floor [ Time Frame: symptom severity scale ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosed Fibromyalgia Syndrome.
  • Limitation of usual activities due to pain on at least 1 day in the previous 30 days.
  • Agreement to attend evening therapy sessions.
  • Non-practice of regular physical activity.

Exclusion Criteria:

  • A history of surgery.
  • The presence of comorbid conditions (e.g., morbid obesity, inflammatory diseases, irritable bowel syndrome and interstitial cystitis).
  • A history of whiplash injury.
  • Severe physical disability.
  • uncontrolled endocrine disorders (e.g., hyperthyroidism, diabetes); 6) illness (e.g., schizophrenia or substance abuse).
  • The use of medication other than as-needed analgesics (excluding long-term narcotics).
  • Malignancy.
  • Psychiatric disorders.
  • A score of ≥ 9 points in the Beck depression inventory.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02859467


Locations
Layout table for location information
Spain
Adelaida María Castro-Sánchez
Almería, Spain, 04120
Sponsors and Collaborators
Universidad de Almeria
Publications:

Layout table for additonal information
Responsible Party: Adelaida María Castro-Sánchez, Professor, Universidad de Almeria
ClinicalTrials.gov Identifier: NCT02859467    
Other Study ID Numbers: UAL-496
First Posted: August 9, 2016    Key Record Dates
Last Update Posted: November 13, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Adelaida María Castro-Sánchez, Universidad de Almeria:
Physical Therapy Modalities
Exercise
Electrical Stimulation Therapy
Bandages
Additional relevant MeSH terms:
Layout table for MeSH terms
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases